Caption Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.83M Buy
16,500
+9,000
+120% +$2.96M 0.03% 542
2025
Q4
$2.63M Hold
7,500
0.02% 741
2025
Q3
$2.42M Buy
+7,500
New +$2.33M 0.02% 769
2025
Q1
Sell
-10,000
Closed -$3.69M 1658
2024
Q4
$3.69M Buy
+10,000
New +$4.18M 0.03% 474
2024
Q3
Sell
-16,000
Closed -$8.67M 1372
2024
Q2
$8.67M Buy
+16,000
New +$8.46M 0.13% 167
2020
Q3
Sell
-25,000
Closed -$6.58M 1087
2020
Q2
$6.58M Buy
+25,000
New +$6.67M 0.22% 123

Other funds holding ELV

Caption Management's ELV Position: Q1 2026 in Review

Caption Management increased its Elevance Health (ELV) stake by 198% in Q1 2026, buying an estimated $1.4M and bringing the position to 6,400 shares worth $1.87M. The position accounts for 0.01% of the portfolio, ranked #839.

Caption Management first reported a position in ELV in Q2 2020 and has held it in 6 quarters since. The position peaked at $5M in Q2 2020. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Caption Management held 6,400 shares of Elevance Health worth $1.87M as of Q1 2026.
  • Caption Management bought 4,250 Elevance Health shares in Q1 2026, an estimated $1.4M.
  • Elevance Health made up 0.01% of Caption Management's portfolio in Q1 2026, its #839 holding.
  • Caption Management first reported a position in Elevance Health in Q2 2020 and has held it in 6 quarters since.
  • Caption Management's Elevance Health position peaked at $5M in Q2 2020.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.